Comments
Loading...

ProKidney Analyst Ratings

PROKNASDAQ
Logo brought to you by Benzinga Data
$2.18
0.031.40%
At close: Jan 21, 4:00 PM EST
$2.19
0.041.86%
Pre-Market: 5:32 AM EST
Consensus Rating1
Buy
Highest Price Target1
$16.00
Lowest Price Target1
$1.00
Consensus Price Target1
$7.75

ProKidney Analyst Ratings and Price Targets | NASDAQ:PROK | Benzinga

ProKidney Corp has a consensus price target of $7.75 based on the ratings of 9 analysts. The high is $16 issued by BTIG on July 25, 2023. The low is $1 issued by B of A Securities on June 30, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., UBS, and Guggenheim on December 16, 2025, July 15, 2025, and July 14, 2025, respectively. With an average price target of $9 between HC Wainwright & Co., UBS, and Guggenheim, there's an implied 310.96% upside for ProKidney Corp from these most-recent analyst ratings.

Analyst Trends and Forecast

1
Dec 25
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
UBS
Guggenheim
Citigroup
B of A Securities

1calculated from analyst ratings

Analyst Ratings for ProKidney

Buy NowGet Alert
12/16/2025Buy Now447.95%HC Wainwright & Co. → $12Initiates → BuyGet Alert
07/15/2025Buy Now265.3%UBS$4 → $8MaintainsBuyGet Alert
07/14/2025Buy Now219.63%Guggenheim$6 → $7MaintainsBuyGet Alert
07/09/2025Buy Now310.96%Citigroup$6 → $9MaintainsBuyGet Alert
06/30/2025Buy Now-54.34%B of A Securities$3 → $1DowngradeNeutral → UnderperformGet Alert
09/30/2024Buy Now—JP Morgan—Initiates → NeutralGet Alert
09/10/2024Buy Now173.97%Guggenheim → $6Initiates → BuyGet Alert
09/04/2024Buy Now36.99%B of A Securities$4 → $3MaintainsNeutralGet Alert
06/10/2024Buy Now173.97%Jefferies$15 → $6MaintainsBuyGet Alert
05/29/2024Buy Now82.65%B of A Securities$3 → $4MaintainsNeutralGet Alert
03/07/2024Buy Now36.99%Morgan Stanley → $3Assumes → Equal-WeightGet Alert
01/02/2024Buy Now-8.68%B of A Securities$8 → $2DowngradeBuy → NeutralGet Alert
07/25/2023Buy Now630.59%BTIG → $16Initiates → BuyGet Alert

FAQ

Q

What is the target price for ProKidney (PROK) stock?

A

The latest price target for ProKidney (NASDAQ:PROK) was reported by HC Wainwright & Co. on December 16, 2025. The analyst firm set a price target for $12.00 expecting PROK to rise to within 12 months (a possible 447.95% upside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for ProKidney (PROK)?

A

The latest analyst rating for ProKidney (NASDAQ:PROK) was provided by HC Wainwright & Co., and ProKidney initiated their buy rating.

Q

When was the last upgrade for ProKidney (PROK)?

A

There is no last upgrade for ProKidney

Q

When was the last downgrade for ProKidney (PROK)?

A

The last downgrade for ProKidney Corp happened on June 30, 2025 when B of A Securities changed their price target from $3 to $1 for ProKidney Corp.

Q

When is the next analyst rating going to be posted or updated for ProKidney (PROK)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProKidney, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProKidney was filed on December 16, 2025 so you should expect the next rating to be made available sometime around December 16, 2026.

Q

Is the Analyst Rating ProKidney (PROK) correct?

A

While ratings are subjective and will change, the latest ProKidney (PROK) rating was a initiated with a price target of $0.00 to $12.00. The current price ProKidney (PROK) is trading at is $2.19, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.